To elucidate the molecular mechanisms by which MRPS7 and MRPS23 drive NPC progression, we performed co-IP combined with mass spectrometry to identify potential regulatory partners of MRPS7 and MRPS23. This evidence concerns the gene MRPS7 and nasopharyngeal carcinoma.